0
0
12/8/23 at 4:00pm
Organization
FDA.gov
Author
Office of the Commissioner
39 words
0
Comments
The FDA approved the first cell-based gene therapies, Casgevy and Lyfgenia, for the treatment of sickle cell disease in patients 12 years and older.
You are the first to view
https://www.fda.gov/news-events/press-announcements/fda-approves-first-gene-therapies-treat-patients-sickle-cell-disease
Create an account
or login to join the discussion